Chindex International, Inc. ("Chindex") (Nasdaq: CHDX), a leading independent American provider of Western healthcare products and services in the People's Republic of China, today announced that it has entered into a contract to supply EUR5 million in laboratory and hospital products to Centers for Disease Control in China's Qinghai Province. The purchase is being financed by the KfW Development Bank of Germany under a government to government program. The signing ceremony was held today in Beijing and the contract is expected to ship during the current fiscal year.
Roberta Lipson, Chindex President and CEO, commented, "Chindex continues to be a key supplier under the KfW program's Centers for Disease Control efforts in China. We are pleased to once again be implementing another KfW program, utilizing the expertise that we have developed in government-sponsored loan projects, to provide an increasingly diversified and robust array of medical and laboratory products to China's healthcare communities."
POINT project launches video to showcase its healthcare advancements